Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Camp Lejeune Injury Claims Expected To Spike Leading Up To Filing Deadline in Aug 2024 Individuals exposed to contaminated water at the Marine base only have about five more months remaining under the Camp Lejeune injury claim filing deadline. April 3, 2024 Irvin Jackson Add Your Comments In August 2022, President Joe Biden signed the Camp Lejeune Justice Act into law, opening a two-year window for veterans, military family members and other individuals injured by contaminated water at the North Carolina U.S. Marine Corps training base to file a claim for financial compensation. The U.S. government has already received more than 175,000 administrative claims filed with the Department of Navy, which is required before any Camp Lejeune injury lawsuit can be filed in court. However, with only a few months remaining until the Camp Lejeune filing deadline, it is widely expected that the number of claims will rise dramatically in the coming weeks. Lawyers are continuing to actively investigate claims involving a wide range of injuries linked to toxic chemicals found in the water at Camp Lejeune, including various types of cancer, Parkinson’s disease, birth defects, fertility problems and other injuries, and the litigation is likely to become one of the largest mass torts in U.S. history by the time the filing window closes on August 10, 2024. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Widespread Settlements Not Being Reached Before Camp Lejeune Lawsuit Filing Deadline Although the U.S. Congress enacted the Camp Lejeune Justice Act to provide individuals with a quick path to receive financial compensation, there have seen substantial delays with the Navy reviewing claims and widespread settlements have not materialized. Last year, the U.S. government announced an elective Camp Lejeune settlement option, providing guaranteed tiers of compensation for veterans and their families if they suffered certain medical conditions, such as kidney cancer, liver cancer, non-Hodgkin’s lymphoma, leukemia, bladder cancer, multiple myeloma, Parkinson’s disease and systemic sclerosis. However, many claimants do not qualify for this settlement, and actual offers have only been provided for a small number of individuals. According to a joint status report (PDF) filed on March 26, only 110 Camp Lejeune claims have been confirmed as eligible for the elective settlement option. Of those, 11 of the offers have been rejected by the claimants, 40 of the offers expired without a response and another 14 are still pending. As a result, only 45 Camp Lejeune settlement payouts have been accepted by claimants. April 2024 Camp Lejeune Lawsuit Update With the filing of new Camp Lejeune injury claims continue to greatly outpace settlements, the U.S. Courts are moving forward with plans to prepare several groups of lawsuits for early trial dates, to help gauge the relative strengths and weaknesses of claims involving different categories of injuries. Late last year, the Court established a first track of Camp Lejeune bellwether lawsuits, and lawyers have selected 100 cases that are currently going through early discovery, including claims that involve: Bladder cancer Kidney cancer Leukemia Parkinson’s disease Non-Hodgkin’s lymphoma In February, the four judges overseeing Camp Lejeune lawsuits announced a Track 2 Discovery Plan Order, involving the following injuries: Prostate Cancer Kidney Disease Lung Cancer Liver Cancer Breast Cancer While the outcome of these early bellwether trials will not have a binding impact on other claims in hte litigation, the amount of any Camp Lejeune lawsuit payouts awarded may help the parties in global settlement negotiations, by demonstrating how judges are likely to respond in future cases involving various types of injuries. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Camp Lejeune, Cancer, Military, North Carolina, Veterans, Veterans Affairs, Water Contamination More Camp Lejeune Lawsuit Stories U.S. Government Seeks Dismissal of Camp Lejeune Kidney Cancer Lawsuits September 15, 2025 Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025 Total Number of Camp Lejeune Injury Claims Drops to 480K, After De-Duplication Process: Report January 9, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCompanyThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025) Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025) Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025
Total Number of Camp Lejeune Injury Claims Drops to 480K, After De-Duplication Process: Report January 9, 2025
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)
Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)